Dorsey & Whitney Trust CO LLC Grows Stock Holdings in Haleon plc (NYSE:HLN)

Dorsey & Whitney Trust CO LLC lifted its stake in Haleon plc (NYSE:HLN) by 18.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,595 shares of the company’s stock after purchasing an additional 3,985 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Haleon were worth $211,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Janney Montgomery Scott LLC increased its holdings in shares of Haleon by 182.3% during the first quarter. Janney Montgomery Scott LLC now owns 438,833 shares of the company’s stock valued at $3,726,000 after acquiring an additional 283,410 shares in the last quarter. Capstone Investment Advisors LLC bought a new stake in shares of Haleon during the first quarter valued at approximately $1,969,000. Wellington Management Group LLP raised its holdings in Haleon by 164.6% in the 4th quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after acquiring an additional 8,423,475 shares during the last quarter. Douglas Lane & Associates LLC lifted its position in Haleon by 2.1% in the 1st quarter. Douglas Lane & Associates LLC now owns 8,401,876 shares of the company’s stock valued at $71,332,000 after acquiring an additional 175,082 shares in the last quarter. Finally, Procyon Advisors LLC boosted its stake in Haleon by 559.9% during the 1st quarter. Procyon Advisors LLC now owns 131,665 shares of the company’s stock valued at $1,118,000 after purchasing an additional 111,713 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

HLN opened at $10.38 on Friday. Haleon plc has a 12-month low of $7.70 and a 12-month high of $10.51. The company has a market cap of $47.40 billion, a price-to-earnings ratio of 34.60, a PEG ratio of 3.04 and a beta of 0.26. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company’s 50 day moving average is $9.54 and its 200 day moving average is $8.78.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.01). The company had revenue of $3.50 billion during the quarter, compared to the consensus estimate of $3.55 billion. Haleon had a return on equity of 13.15% and a net margin of 9.71%. During the same period last year, the business earned $0.08 EPS. On average, equities research analysts predict that Haleon plc will post 0.46 EPS for the current year.

Haleon Cuts Dividend

The business also recently announced a semi-annual dividend, which will be paid on Thursday, September 19th. Investors of record on Friday, August 16th will be given a dividend of $0.0514 per share. The ex-dividend date of this dividend is Friday, August 16th. This represents a dividend yield of 1.6%. Haleon’s dividend payout ratio is 33.33%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Berenberg Bank assumed coverage on shares of Haleon in a research note on Tuesday, August 6th. They set a “buy” rating on the stock. The Goldman Sachs Group downgraded shares of Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.